Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
AboutMethodSourcesNewsletter
StockCIK 1796280

Oric Pharmaceuticals, Inc. (ORIC): Insider Trades and Fund Holdings

In the past 12 months, Oric Pharmaceuticals, Inc. insiders reported 0 open-market purchases worth $0 and 6 sales worth $1.52M; 6 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$1.52MSold by insiders, 12 months
1Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.

  1. Oct 20, 2026Insider saleCFO Dominic Piscitelli sold $189,391 under a 10b5-1 plan
  2. Oct 1, 2026Insider saleDirector Richard A. Heyman sold $86,524 under a 10b5-1 plan
  3. Oct 1, 2026Planned saleRichard A, Heyman (director) filed notice to sell about $109,107 around Oct 1, 2026
  4. Oct 1, 2026Planned saleRichard A, Heyman (director) filed notice to sell about $102,372 around Oct 1, 2026
  5. Sep 28, 2026Insider saleCFO Dominic Piscitelli sold $181,258 under a 10b5-1 plan
  6. Sep 24, 2026Insider saleCFO Dominic Piscitelli sold $8,103 under a 10b5-1 plan
  7. Aug 26, 2026Insider saleCFO Dominic Piscitelli sold $1.1 million under a 10b5-1 plan
  8. Jun 30, 2026FundViking Global Investors cut 12% in Q2 2026 (13F filed Aug 14, 2026)

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 21, 2026.

Recent ORIC insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 21Oct 20Dominic PiscitelliCFOCFO▼ SELL10b5-114,00013.53$189K−17%Form 4 ↗
Oct 2Oct 1Richard A. HeymanDirectorDirector▼ SELL10b5-13,50012.91$45K−8.4%Form 4 ↗
Oct 2Oct 1Richard A. HeymanDirectorDirector (ind.)▼ SELL10b5-13,20012.91$41K−1.5%Form 4 ↗
Sep 29Sep 28Dominic PiscitelliCFOCFO▼ SELL10b5-113,40013.53$181K−16%Form 4 ↗
Sep 25Sep 24Dominic PiscitelliCFOCFO▼ SELL10b5-160013.51$8K−0.9%Form 4 ↗
Aug 28Aug 26Dominic PiscitelliCFOCFO▼ SELL10b5-177,00013.69$1.05M−52%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Dominic PiscitelliCFO0$04$1.43MOct 21, 2026
Richard A. HeymanDirector0$02$87KOct 2, 2026

Buybacks and executive pay

YearCEO pay reportedCEO pay "actually paid"Value of $100 invested
2025$5.57M$5.69Mn/a
2024$5.28M$4.27Mn/a

From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.

Tracked funds that report ORIC

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Viking Global InvestorsQ2 20265,126,762$55.5M0.16%▼ −12.0%
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →